These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15367824)

  • 1. Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
    Vereckei A; Gorski JC; Ujhelyi M; Mehra R; Zipes DP
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):269-77. PubMed ID: 15367824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
    Vereckei A; Warman E; Mehra R; Zipes DP
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation.
    Chou CC; Zhou S; Tan AY; Hayashi H; Nihei M; Chen PS
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2704-13. PubMed ID: 16055519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation.
    Sun JL; Han R; Guo JH; Li XY; Ma XL; Wang CY
    Cell Biochem Biophys; 2012 Dec; 64(3):197-203. PubMed ID: 22740072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.
    Morillo CA; Klein GJ; Jones DL; Guiraudon CM
    Circulation; 1995 Mar; 91(5):1588-95. PubMed ID: 7867201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
    Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
    Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
    Sasaki N; Watanabe I; Kogawa R; Sonoda K; Takahashi K; Okumura Y; Ohkubo K; Nakai T; Hirayama A
    Int Heart J; 2014; 55(3):244-8. PubMed ID: 24806377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization.
    Nabih MA; Prcevski P; Fromm BS; Lavine SJ; Elnabtity M; Munir A; Steinman RT; Meissner MD; Lehmann MH
    Pacing Clin Electrophysiol; 1993 Oct; 16(10):1975-83. PubMed ID: 7694244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.
    Oshikawa N; Watanabe I; Masaki R; Shindo A; Kojima T; Saito S; Ozawa Y; Kanmatsuse K
    J Interv Card Electrophysiol; 2001 Mar; 5(1):81-7. PubMed ID: 11248779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.
    Sticherling C; Hsu W; Tada H; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Electrophysiol; 2002 Feb; 13(2):151-7. PubMed ID: 11900290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
    Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
    Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
    Stambler BS; Wood MA; Ellenbogen KA
    Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
    Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S
    Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
    Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode.
    Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
    Sonoda K; Watanabe I; Ohkubo K; Okumura Y; Kofune M; Sasaki N; Kogawa R; Mano H; Nakai T; Hirayama A
    Int Heart J; 2013; 54(5):279-84. PubMed ID: 24097216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.